• ICare4Autism

Technology, Pharmaceutical Companies Create Digital Therapeutic Platform for People With Autism

Harman, a subsidiary of Samsung Electronics specializing in connected technologies for automotive and enterprise markets, announced a global partnership this week with the Swiss pharmaceutical company Roche to create a digital therapeutic platform for people with autism spectrum disorder (ASD). “We are excited to work with HARMAN to leverage both company’s capabilities, in order to develop novel solutions that will support individuals living with ASD, their caregivers and healthcare professionals”, James Sabry, Global Head of Roche Pharma Partnering, was quoted as saying in a report by AP News. “We believe that digital behavioral therapy may address some of the challenges of daily life for people living with ASD and potentially expand the treatment modalities.” Roche’s digital therapeutic platform will draw on Harman’s consumer and healthcare expertise to help individuals on the autism spectrum. David Slump, president of Connected Services, Harman, described the partnership as “a significant opportunity to apply innovative technologies and enable advanced care for ASD that can positively impact the day-to-day life of individuals and their families who are affected.” “We are honored and excited to collaborate with an esteemed partner like Roche,” Slump continued, “who drove and originated this partnership. Roche will lead the clinical development, regulatory and commercial strategy, while HARMAN will provide the enabling technology. Together, we are aiming to provide user-centric connected solutions that focus on behavioral therapy to improve social communication for individuals with ASD, increase efficiency, and ultimately boost personalized healthcare access.” Source:

48 views0 comments